powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1679784524
Nebu Koshy
M.D.
Hematology-Oncology
Dallas,
TX
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
856
Unique beneficiaries
—
Total services
5,637
Distinct HCPCS
32
Medicare payment
$182K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 613 Hematology-Oncology providers in TX — above median (cohort median 2,625).
PRESCRIBING · PART D · 2024
Total Rx claims
614
Beneficiaries
—
Total drug cost
$1.3M
Distinct drugs
27
Brand share
38.9%
Top prescribed drugs
Valacyclovir Hcl
84 claims
Amlodipine Besylate
44 claims
Acyclovir
43 claims
Levofloxacin
41 claims
Entecavir
34 claims
QUALITY · MIPS · 2024
Final MIPS score
85.1
Quality
67.5
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.43%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$490
Payment records
20
By payment type
Food and Beverage
$490
Top paying entities
Food and Beverage
$490
